array(3) { ["company_details"]=> array(13) { ["name"]=> string(26) "Natus Medical Incorporated" ["slug"]=> string(35) "05e48-us-natus-medical-incorporated" ["logo"]=> string(84) "https://images.businessradar.com/linkedin_logos/a15c3f67-a529-4950-a831-d87d6d0fff2a" ["description"]=> string(897) "Natus Medical Incorporated (Natus) offers medical equipment, software, supplies and services for the diagnosis, monitoring, and treatment of impairments and disorders effecting the brain, neural pathways, and eight sensory nervous systems. Our comprehensive product portfolio represents a heritage of innovation and leadership. Natus brands have been setting the standard for patient care for over eighty (80) years. Our products are trusted by medical professionals in university medical centers, hospitals, private practices, clinics and research laboratories around the world. Natus does not endorse personal/non-work related comments made by employees on social media. Further, Natus values the respect and inclusion of all people without regard to race, color, religion, sex, national origin, veteran status, disability, sexual orientation, gender identity, or any other protected status." ["address_street"]=> string(29) "6701 Koll Center Pkwy Ste 120" ["address_place"]=> string(10) "Pleasanton" ["address_region"]=> string(10) "California" ["founding_date"]=> string(10) "1987-02-13" ["website_domain"]=> string(9) "natus.com" ["website_url"]=> string(17) "https://natus.com" ["industry_codes"]=> array(1) { [0]=> string(47) "Electromedical and Electrotherapeutic Apparatus" } ["employee_count"]=> int(1480) ["article_count"]=> int(149) } ["articles"]=> array(1) { [0]=> array(7) { ["title_en"]=> string(61) "Natus Medical Announces Second Quarter 2020 Financial Results" ["snippet_en"]=> string(164) "Q2-2020 Key ResultsRevenue (millions)$84.8 • Newborn Care revenue increased 1% compared to second quarter last year • Reduced debt by $13.0 million during..." ["url"]=> string(133) "https://www.globenewswire.com/news-release/2020/07/30/2070665/0/en/Natus-Medical-Announces-Second-Quarter-2020-Financial-Results.html" ["image_url"]=> string(78) "https://images.businessradar.com/articles/d9acc2f3-d446-4adf-9650-8fd2103c1a0c" ["source"]=> string(17) "globenewswire.com" ["publication_date"]=> string(10) "2020-07-30" ["categories"]=> array(3) { [0]=> string(24) "Quarterly/Annual Figures" [1]=> string(5) "Debts" [2]=> string(12) "Restatements" } } } ["category_annotations"]=> array(30) { [0]=> array(2) { ["name"]=> string(11) "Acquisition" ["count"]=> int(23) } [1]=> array(2) { ["name"]=> string(24) "Quarterly/Annual Figures" ["count"]=> int(12) } [2]=> array(2) { ["name"]=> string(12) "Stock Market" ["count"]=> int(11) } [3]=> array(2) { ["name"]=> string(10) "Litigation" ["count"]=> int(7) } [4]=> array(2) { ["name"]=> string(12) "Board Change" ["count"]=> int(7) } [5]=> array(2) { ["name"]=> string(15) "Market Movement" ["count"]=> int(5) } [6]=> array(2) { ["name"]=> string(5) "Legal" ["count"]=> int(4) } [7]=> array(2) { ["name"]=> string(46) "Management of Legal and Regulatory Environment" ["count"]=> int(4) } [8]=> array(2) { ["name"]=> string(5) "R & D" ["count"]=> int(4) } [9]=> array(2) { ["name"]=> string(13) "Credit Rating" ["count"]=> int(3) } [10]=> array(2) { ["name"]=> string(10) "Executives" ["count"]=> int(3) } [11]=> array(2) { ["name"]=> string(31) "Financial Update/Profit Warning" ["count"]=> int(3) } [12]=> array(2) { ["name"]=> string(14) "Issuing Shares" ["count"]=> int(3) } [13]=> array(2) { ["name"]=> string(5) "SPACs" ["count"]=> int(3) } [14]=> array(2) { ["name"]=> string(11) "Name Change" ["count"]=> int(2) } [15]=> array(2) { ["name"]=> string(18) "General Investment" ["count"]=> int(2) } [16]=> array(2) { ["name"]=> string(25) "Business Model Resilience" ["count"]=> int(2) } [17]=> array(2) { ["name"]=> string(12) "Staff hiring" ["count"]=> int(2) } [18]=> array(2) { ["name"]=> string(10) "Downsizing" ["count"]=> int(2) } [19]=> array(2) { ["name"]=> string(19) "Economic Conditions" ["count"]=> int(2) } [20]=> array(2) { ["name"]=> string(18) "Expansion & Growth" ["count"]=> int(2) } [21]=> array(2) { ["name"]=> string(20) "Corporate Governance" ["count"]=> int(2) } [22]=> array(2) { ["name"]=> string(17) "Academic Research" ["count"]=> int(2) } [23]=> array(2) { ["name"]=> string(22) "Shareholder Reputation" ["count"]=> int(2) } [24]=> array(2) { ["name"]=> string(21) "Competitive Behaviour" ["count"]=> int(1) } [25]=> array(2) { ["name"]=> string(17) "Business Disputes" ["count"]=> int(1) } [26]=> array(2) { ["name"]=> string(15) "Blogs & Columns" ["count"]=> int(1) } [27]=> array(2) { ["name"]=> string(6) "Merger" ["count"]=> int(1) } [28]=> array(2) { ["name"]=> string(9) "Pollution" ["count"]=> int(1) } [29]=> array(2) { ["name"]=> string(17) "Production Issues" ["count"]=> int(1) } } } 05e48-us-natus-medical-incorporated